Study * (AADR) Alpha1-Antitrypsin Deficiency Registry (AADR) (ACCESS) A Case Controlled Etiologic Study of Sarcoidosis (ACCESS) (ACCORD) Action to Control Cardiovascular Risk in Diabetes (ACCORD) (ACIP) Asymptomatic Cardiac Ischemia Pilot Study (ACIP) (ACRN-BAGS) Asthma Clinical Research Network (ACRN) Beta Agonist in Mild Asthma Study (BAGS) (ACRN-BARGE) Asthma Clinical Research Network (ACRN) Beta Adrenergic Response by Genotype (BARGE) (ACRN-BASALT/TALC) Asthma Clinical Research Network Trial (ACRN) - Best Adjustment Strategy for Asthma in Long Term (BASALT) and Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) (ACRN-CIMA) Asthma Clinical Research Network (ACRN) Colchicine In Moderate Asthma (CIMA) (ACRN-DICE) Asthma Clinical Research Network (ACRN) Dose of Inhaled Corticosteroids with Equisystemic Effects (DICE) (ACRN-IMPACT) Asthma Clinical Research Network (ACRN) IMProving Asthma Control Trial (IMPACT) (ACRN-LARGE) Asthma Clinical Research Network Trial (ACRN) - Long-Acting Beta Agonist Response by Genotype (LARGE) (ACRN-MIA) Asthma Clinical Research Network Trial (ACRN) - Macrolides in Asthma (MIA) (ACRN-MICE) Asthma Clinical Research Network (ACRN) Measuring Inhaled Corticosteroid Efficacy (MICE) (ACRN-PRICE) Asthma Clinical Research Network (ACRN) Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) (ACRN-SLiMSIT) Asthma Clinical Research Network (ACRN) Salmeterol and Leukotriene Modifiers vs. Salmeterol and ICS Treatment (SLiMSIT) (ACRN-SMOG) Asthma Clinical Research Network (ACRN) Smoking Modulates Outcomes of Glucocorticoid Therapy in Asthma (SMOG) (ACRN-SOCS/SLIC) Asthma Clinical Research Network (ACRN) Salmeterol Off CorticoSteroids (SOCS) and Salmeterol Inhaled Corticosteroids (SLIC) (ACS-QUIK) Acute Coronary Syndrome Quality Improvement in Kerala (ACS-QUIK) Cluster Randomized, Stepped Wedge Multi-center Implementation of a Locally-Developed Quality Improvement Toolkit (ACT) Activity Counseling Trial (ACT) (AFFIRM) Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) (AIM-HIGH) Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes (AIM-HIGH) (ALLHAT) Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (AMIS) Aspirin-Myocardial Infarction Study (AMIS) (ARDSNet-ALTA) Acute Respiratory Distress Network (ARDSNet) Studies 06 and 08 Prospective, Randomized, Multicenter Trial of Aerosolized Albuterol Versus Placebo for the Treatment of Acute Lung Injury (ALTA) (ARDSNet-ALVEOLI) Acute Respiratory Distress Network (ARDSNet) Study 04 Assessment of Low tidal Volume and elevated End-expiratory volume to Obviate Lung Injury (ALVEOLI) (ARDSNet-ARMA/KARMA/LARMA) Acute Respiratory Distress Network (ARDSNet) Studies 01 and 03 Lower versus higher tidal volume, ketoconazole treatment and lisofylline treatment (ARMA/KARMA/LARMA) (ARDSNet-EDEN) Acute Respiratory Distress Network (ARDSNet) Studies 07, 08, 09, 11, and 12 Early Versus Delayed Enteral Feeding to Treat People with Acute Lung Injury or Acute Respiratory Distress Syndrome (EDEN) (ARDSNet-FACTT) Acute Respiratory Distress Network (ARDSNet) Study 05 Fluid and Catheter Treatment Trial (FACTT) (ARDSNet-LASRS) Acute Respiratory Distress Network (ARDSNet) Study 02 Late Steroid Rescue Study (LaSRS) (ARDSNet-Omega) Acute Respiratory Distress Network (ARDSNet) Studies 07 and 08 Prospective, Randomized, Blinded, Placebo-controlled, Multi-center Trial of Omega-3 Fatty Acid, Gamma-Linolenic Acid, and Anti-Oxidant Supplementation in the Management of Acute Lung Injury or Acute Respiratory Distress Syndrome (Omega) (ARDSNet-SAILS) Acute Respiratory Distress Network (ARDSNet) Studies 10 and 12 Statins for Acutely Injured Lungs from Sepsis (SAILS) (ARIC) Atherosclerosis Risk in Communities Study (ARIC) (ATTRACT) Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis (ATTRACT) (AVID) Antiarrhythmics Versus Implantable Defibrillators (AVID) (AsthmaNet-ALFA) AsthmaNet Proof of Concept Study of Alendronate for Asthma (ALFA) (AsthmaNet-APRIL/OCELOT) AsthmaNet Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children (APRIL) and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children (OCELOT) (AsthmaNet-BARD) AsthmaNet Best African American Response to Asthma Drugs (BARD) (AsthmaNet-INFANT/AVICA) AsthmaNet Individualized Therapy For Asthma in Toddlers (INFANT) and Acetaminophen Versus Ibuprofen in Children With Asthma (AVICA) (AsthmaNet-Microbiome) AsthmaNet Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment (AsthmaNet-SIENA) AsthmaNet Steroids in Eosinophil Negative Asthma (SIENA) (AsthmaNet-STICS) AsthmaNet Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) (AsthmaNet-VIDA) AsthmaNet Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma (VIDA) (BABY HUG) Hydroxyurea to Prevent Organ Damage in Children with Sickle Cell Anemia (BABY HUG) Phase III Clinical Trial and Follow-Up Observational Studies I and II (BARI) Bypass Angioplasty Revascularization Investigation (BARI) (BARI 2D) Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) (BEST) Beta-Blocker Evaluation in Survival Trial (BEST) (BEST-COPD) Broccoli Sprouts Extracts Trial (BEST-COPD) (BHAT) Beta-Blocker Heart Attack Trial (BHAT) (BHS) Bogalusa Heart Study (BHS) (BMT CTN-0101) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants (0101) (BMT CTN-0102) Blood and Marrow Clinical Trials Network (BMT CTN) A Trial of Tandem Autologous Stem Cell Transplants +/- Post Second Autologous Transplant Maintenance Therapy Versus Single Autologous Stem Cell Transplant Followed by Matched Sibling Non-myeloablative Allogeneic Stem Cell Transplant for Patients With Multiple Myeloma (0102) (BMT CTN-0201) Blood and Marrow Clinical Trials Network (BMT CTN) Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers (0201) (BMT CTN-0301) Blood and Marrow Clinical Trials Network (BMT CTN) Fludarabine-based Conditioning for Severe Aplastic Anemia (0301) (BMT CTN-0302) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil, Denileukin Diftitox, and Pentostatin in Combination With Corticosteroids for Initial Systemic Treatment of Acute Graft-Versus-Host Disease (0302) (BMT CTN-0401) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Phase III Rituxan/BEAM vs. Bexxar/BEAM With Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Persistent or Relapsed Chemotherapy Sensitive Diffuse Large B-cell Non-Hodgkin's Lymphoma (0401) (BMT CTN-0402) Blood and Marrow Clinical Trials Network (BMT CTN) A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (0402) (BMT CTN-0403) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) A Randomized Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Cell Transplantation (0403) (BMT CTN-0501) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Multi-center, Open Label, Randomized Trial Comparing Single Versus Double Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia (0501) (BMT CTN-0601) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Unrelated Donor Reduced Intensity Bone Marrow Transplant for Children With Severe Sickle Cell Disease (0601) (BMT CTN-0603) Blood and Marrow Clinical Trials Network (BMT CTN) Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (0603) (BMT CTN-0604) Blood and Marrow Clinical Trials Network (BMT CTN) A Multi-Center, Phase II Trial of Non-Myeloablative Conditioning (NST) and Transplantation of Umbilical Cord Blood (UCB) From Unrelated Donors in Patients With Hematologic Malignancies (0604) (BMT CTN-0701) Blood and Marrow Clinical Trials Network (BMT CTN) A Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response (0701) (BMT CTN-0702) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) A Trial of Single Autologous Transplant With or Without Consolidation Therapy Versus Tandem Autologous Transplant With Lenalidomide Maintenance for Patients With Multiple Myeloma (0702) (BMT CTN-0801) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) A Phase II/III Randomized, Multicenter Trial Comparing Sirolimus Plus Prednisone and Sirolimus/Calcineurin Inhibitor Plus Prednisone for the Treatment of Chronic Graft-versus-Host Disease (0801) (BMT CTN-0802) Blood and Marrow Clinical Trials Network (BMT CTN) A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids with Mycophenolate Mofetil vs. Corticosteroids with Placebo as Initial Systemic Treatment of Acute GVHD (0802) (BMT CTN-0803) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (0803) (BMT CTN-0901) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia (0901) (BMT CTN-0902) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) A Phase III Randomized, Multicenter Trial Testing Whether Exercise or Stress Management Improves Functional Status and Symptoms of Autologous and Allogeneic Recipients (0902) (BMT CTN-0903) Blood and Marrow Clinical Trials Network (BMT CTN) Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals (0903) (BMT CTN-1101) Blood and Marrow Clinical Trials Network (BMT CTN) A Multi-Center, Phase III, Randomized Trial of RIC, and Transplantation of (dUCB) Versus HLA-Haplo Related Bone Marrow for Patients with Hematologic Malignancies (1101) (BMT CTN-1102) Blood and Marrow Clinical Trials Network (BMT CTN) A Multi-Center Biologic Assignment Trial Comparing Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients with Intermediate-2 & High Risk Myelodysplastic Syndrome (1102) (BMT CTN-1202) Blood and Marrow Clinical Trials Network (BMT CTN) Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT (1202) (BMT CTN-1203) Blood and Marrow Clinical Trials Network (BMT CTN) A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (1203) (BMT CTN-1204) Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Reduced Intensity Conditioning for Children and Adults With Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (1204) (BMT CTN-1301) Blood and Marrow Clinical Trials Network (BMT CTN) Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (1301) (BMT CTN-1302) Blood and Marrow Clinical Trials Network (BMT CTN) Multicenter Phase II, Double-blind Placebo Controlled Trial of Maintenance Ixazomib After Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma (1302) (BMT CTN-1501) Blood and Marrow Clinical Trials Network (BMT CTN) A Randomized, Phase II, Multicenter, Open Label, Study Evaluating Sirolimus and Prednisone in Patients With Refined Minnesota Standard Risk, Ann Arbor 1/2 Confirmed Acute Graft-Versus-Host Disease (1501) (BRIDGE) Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery (BRIDGE) (CABANA) Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA) (CABG) Post Coronary Artery Bypass Graft Study (CABG) (CAMP) Childhood Asthma Management Program (CAMP) (CAPTION) Collaboration Among Pharmacists and Physicians to Improve Outcomes Now (CAPTION) (CARDIA) Coronary Artery Risk Development in Young Adults (CARDIA) (CARE-AIMS) Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS) (CARE-BADGER) Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER) (CARE-CLIC) Childhood Asthma Research and Education (CARE) Network Characterizing the Response to a Leukotriene Receptor Antagonist and an Inhaled Corticosteroid (CLIC) (CARE-MARS) Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS) (CARE-MIST) Childhood Asthma Research and Education (CARE) Network Trial – Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST) (CARE-PACT) Childhood Asthma Research and Education (CARE) Network Trial - Pediatric Asthma Controller Trial (PACT) (CARE-PEAK) Childhood Asthma Research and Education (CARE) Network Trial - Prevention of Early Asthma in Kids (PEAK) (CARE-TREXA) Childhood Asthma Research and Education (CARE) Network Trial - Treating children to Prevent Exacerbations of Asthma (TREXA) (CASS) Coronary Artery Surgery Study (CASS) (CAST) Cardiac Arrhythmia Suppression Trial (CAST) (CBB) NHLBI Umbilical Cord Blood Unit Collection (CBB) (CCTRN-FOCUS) Cardiovascular Cell Therapy Research Network (CCTRN) Randomized, Controlled, Phase II, Double-Blind Trial of Intramyocardial Injection of Autologous Bone Marrow Mononuclear Cells Under Electromechanical Guidance for Patients With Chronic Ischemic Heart Disease and Left Ventricular Dysfunction (FOCUS) (CCTRN-LateTIME) Cardiovascular Cell Therapy Research Network (CCTRN) A Phase II, Randomized, Controlled, Double-Blind Pilot Trial Evaluating the Safety and Effect of Administration of Bone Marrow Mononuclear Cells Two to Three Weeks Following Acute Myocardial Infarction (LateTIME) (CCTRN-PACE) Cardiovascular Cell Therapy Research Network (CCTRN) Clinical and MR Imaging Assessments in Patients With Intermittent Claudication Following Injection of Bone Marrow Derived ALDH Bright Cells (PACE) (CCTRN-SENECA) Cardiovascular Cell Therapy Research Network (CCTRN) A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy (SENECA) (CCTRN-TIME) Cardiovascular Cell Therapy Research Network (CCTRN) Transplantation in Myocardial Infarction Evaluation (TIME) Protocol: A Phase II, Randomized, Controlled, Double-Blind Trial Evaluating the Effect of Timing on the Administration of Bone Marrow Mononuclear Cells (BMMNCs) Versus Placebo in Patients With Acute Myocardial Infarction (CDP) Coronary Drug Project (CDP) (CHAT) A Randomized Controlled Study of Adenotonsillectomy for Children with Obstructive Sleep Apnea Syndrome (CHAT) (CHIVES) Coupons for Healthy Intake Using Variable Economic Strategies (CHIVES) (CHOICES) Choosing Healthy Options in College Environments and Settings (CHOICES) (CHS) Cardiovascular Health Study (CHS) (CLEVER) Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) (COAG) Clarification of Optimal Anticoagulation Through Genetics (COAG) (COBLT) Cord Blood Transplantation Study (COBLT) (COLCORONA) Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) (COPTR) Childhood Obesity Prevention and Treatment Research consortium (COPTR) Now Everybody Together for Amazing and Healthful Kids (NET-Works); Growing Right Onto Wellness (GROW); Ideas Moving Parents and Adolescents to Change Together (IMPACT); Clinic, Family & Community Collaboration to Treat Overweight and Obese Children (Stanford GOALS) (CORAL) Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) (CPAP) Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients With Asthma (CPAP) (CSSCD) Cooperative Study of Sickle Cell Disease (CSSCD) (CTSN-POAF) Cardiothoracic Surgical Trials Network (CTSN) Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation (POAF) (CTSN-SMR) Cardiothoracic Surgical Trials Network (CTSN) Evaluation of Outcomes Following Mitral Valve Repair/Replacement in Severe Chronic Ischemic Mitral Regurgitation (SMR) (CTSN/CCTRN-LVAD) Cardiothoracic Surgical Trials Network (CTSN) and Cardiovascular Cell Therapy Research Network (CCTRN) Left Ventricular Assist Device Therapy: Exploring the Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function (LVAD) (CureSCi-HCT for SCD) Cure Sickle Cell Initiative (CureSCi) - Hematopoietic Cell Transplant for Sickle Cell Disease (HCT for SCD) (CureSCi-SCBank) Cure Sickle Cell Initiative (CureSCi) - Sickle Cell Hematopoietic Stem Cell Bank (SCBank) (DASH) Dietary Approaches to Stop Hypertension (DASH) (DASH-Sodium) Dietary Approaches to Stop Hypertension - Sodium Study (DASH-Sodium) (DELTA) Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA) (DIG) Digitalis Investigation Group (DIG) (DISC) Dietary Intervention Study in Children (DISC) (DISC06) Dietary Intervention Study in Children Follow-Up Study (DISC06) (ENRICHD) Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) (EPIC) Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa Airway Infection in Young Patients with Cystic Fibrosis (EPIC) (ESCAPE) Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) (FHS-Cohort) Framingham Heart Study-Cohort (FHS-Cohort) (FHS-Gen III) Framingham Heart Study (FHS) Third Generation (Gen III), OMNI 2, and New Offspring (NOS) Cohorts (FHS-OS) Framingham Heart Study (FHS) Offspring (OS) and OMNI 1 Cohorts (FOCUS) Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS) (GHCoE-Argentina) Global Health Centers of Excellence (GHCoE) Argentina (GHCoE-China) Global Health Centers of Excellence (GHCoE) China (GHCoE-Guatemala) Global Health Centers of Excellence (GHCoE) Guatemala (GHCoE-New Delhi) Global Health Centers of Excellence (GHCoE) New Delhi (GHCoE-South Africa) Global Health Centers of Excellence (GHCoE) South Africa (GUIDE-IT) Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) (GenTAC) National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) (H1N1) Novel Influenza A Surveillance Registry (H1N1) (HCHS-SOL) Hispanic Community Health Study / Study of Latinos (HCHS-SOL) (HCS) Healthy Communities Study (HCS) (HDFP) Hypertension Detection and Follow-Up Program (HDFP) (HEIRS) Hemochromatosis and Iron Overload Screening Study (HEIRS) (HF-ACTION) Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) (HFN-ATHENA HF) Heart Failure Network (HFN) Aldosterone Targeted Neurohormonal Combined with Natriuresis Therapy - HF (ATHENA HF) (HFN-CARRESS) Heart Failure Network (HFN) CARdiorenal REScue Study in Acute Decompensated Heart Failure (CARRESS) (HFN-DOSE AHF) Heart Failure Network (HFN) Diuretic Optimization Strategies Evaluation in Acute Heart Failure (DOSE AHF) (HFN-EXACT HF) Heart Failure Network (HFN) Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT HF) (HFN-FIGHT) Heart Failure Network (HFN) Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT) (HFN-INDIE) Heart Failure Network (HFN) Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF (INDIE) (HFN-IRONOUT) Heart Failure Network (HFN) Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure (IRONOUT) (HFN-NEAT) Heart Failure Network (HFN) Nitrate's Effect on Activity Tolerance in Heart Failure with Preserved Ejection Fraction (NEAT) (HFN-RELAX) Heart Failure Network (HFN) Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure (RELAX) (HFN-ROSE) Heart Failure Network (HFN) Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea (ROSE) (HHL) Heart Healthy Lenoir Project (HHL) (HHP) Honolulu Heart Program (HHP) (HIFI) High Frequency Ventilation in Premature Infants (HIFI) (HIT RADIO) Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study (HIT-RADIO) (ICARE) Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care (ICARE) (IDEA) Innovative Approaches for Diet, Exercise, and Activity (IDEA) (IPFNet-ACE IPF) Idiopathic Pulmonary Fibrosis Network (IPFnet) AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE IPF) (IPFNet-PANTHER IPF) Idiopathic Pulmonary Fibrosis Network (IPFnet) Prednisone, Azathioprine, and N-Acetylcysteine: A Study That Evaluates Response in Idiopathic Pulmonary Fibrosis (PANTHER IPF) (IPFNet-STEP IPF) Idiopathic Pulmonary Fibrosis Network (IPFnet) Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis (STEP IPF) (IPPB) Clinical Study of Intermittent Positive Pressure Breathing (IPPB) (ISCHEMIA/ISCHEMIA-CKD) International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) and ISCHEMIA - Chronic Kidney Disease (ISCHEMIA - CKD) (Intermacs) Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs) (JHS) The Jackson Heart Study (JHS) (LHMP) The Lung HIV Microbiome Project (LHMP) (LHS) Lung Health Study (LHS) (LOTT) Long-term Oxygen Treatment Trial (LOTT) (LRC-CPPT) Lipid Research Clinics (LRC) Coronary Primary Prevention Trial (CPPT) (LRC-PS) Lipid Research Clinics (LRC) Prevalence Study (PS) (LTRC) Lung Tissue Research Consortium (LTRC) (Lung HIV) Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV) (MAGIC) Magnesium in Coronaries (MAGIC) (MASM) New Data Analysis Methods for Actigraphy in Sleep Medicine (MASM) (MEDFOCUS) MEDication Focused Outpatient Care for Underutilization of Secondary Prevention (MEDFOCUS) (MESA) Multi-Ethnic Study of Atherosclerosis (MESA) (MHCS) Multicenter Hemophilia Cohort Studies (MHCS) (MRFIT) Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT) (MSH) Multicenter Study of Hydroxyurea (MSH) (NANB-TAH) Natural History Study of Non-A, Non-B Post-Transfusion Hepatitis (NANB-TAH) (NETT) National Emphysema Treatment Trial (NETT) (NGHS) NHLBI Growth and Health Study (NGHS) (OAT) Occluded Artery Trial (OAT) (OMNI Heart) Optimal Macronutrient Intake Trial to Prevent Heart Disease (OMNI Heart) (P2C2) Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) (PACS) Pulmonary Complications of HIV Infection Study (PACS) (PACTG) Anti-HIV Immunoglobulin in Prevention of Maternal-Fetal HIV Transmission: Pediatric AIDS Clinical Trials Group protocol 185 (PACTG) (PAD) Public Access Defibrillation Community Trial (PAD) (PATHS) Prevention and Treatment of Hypertension Study (PATHS) (PEACE) Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE) (PETAL-BLUE CORAL) Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Biology and Longitudinal Epidemiology of PETAL COVID-19 Observational Study (BLUE CORAL) (PETAL-CLOVERS) Prevention and Early Treatment of Acute Lung Injury (PETAL) Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS) (PETAL-LOTUS FRUIT) Prevention and Early Treatment of Acute Lung Injury (PETAL) Network - Low Tidal Volume Universal Support Feasibility of Recruitment for Interventional Trial (LOTUS FRUIT) (PETAL-ORCHID) Prevention and Early Treatment of Acute Lung Injury (PETAL) Network - Outcomes Related to COVID-19 treated with Hydroxychloroquine among In-patients with symptomatic Disease (ORCHID) (PETAL-RED CORAL) Prevention and Early Treatment of Acute Lung Injury (PETAL) Network - Repository of Electronic Data COVID-19 Observational Study (RED CORAL) (PETAL-ROSE) Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) (PETAL-VIOLET) Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET) (PF-ILD Proteomics) Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis (PF-ILD Proteomics) (PIMI) Psychophysiological Investigation of Myocardial Ischemia (PIMI) (PIOPED) Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) (PLADO) Determination of the Optimal Prophylactic Platelet Dose Strategy to Prevent Bleeding in Thrombocytopenic Patients (PLADO) (POWER-UP) Practice Based Opportunities for Weight Reduction Trial at the University of Pennsylvania (POWER-UP) (PPH Registry) Patient Registry for Primary Pulmonary Hypertension (PPH Registry) (PREMIER) PREMIER: Lifestyle Interventions for Blood Pressure Control (PREMIER) (PRHHP) Puerto Rico Heart Health Program (PRHHP) (PRIDE) PRograms to Increase Diversity among Individuals Engaged in Health-related Research (PRIDE) (PROMISE) Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) (PROP) Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol (REACT) Rapid Early Action for Coronary Treatment (REACT) (REDS II-CORE) Retrovirus Epidemiology Donor Study-II (REDS II) Donation and Deferral Database (CORE) (REDS II-Chagas) Retrovirus Epidemiology Donor Study-II (REDS II) Natural History of Disease and Laboratory Findings in Trypanosoma Cruzi Antibody-Positive Brazilian Blood Donors (Chagas) (REDS II-LAPS) Retrovirus Epidemiology Donor Study-II (REDS II) Leukocyte Antibodies Prevalence Study (LAPS) (REDS II-MS) Retrovirus Epidemiology Donor Study-II (REDS II) Molecular Surveillance (MS) (REDS II-RISE) Retrovirus Epidemiology Donor Study-II (REDS II) Donor Iron Status Evaluation Study (RISE) (REDS III) Recipient Epidemiology and Donor Evaluation Study III (REDS III) Vein to Vein Databases (REDS III-U.S. Zika) Recipient Epidemiology and Donor Evaluation Study III (REDS III) U.S. Natural History Cohort of Zika Virus RNA Positive Blood Donors (U.S. Zika) (REDS-GLPR) Retrovirus Epidemiology Donor Study (REDS) General Leukocyte/Plasma Repository (GLPR) (REDS-HTLV) Retrovirus Epidemiology Donor Study (REDS) HTLV Cohort (HTLV) (REDS-RADAR) Retrovirus Epidemiology Donor Study (REDS) Allogeneic Donor and Recipient Repository (RADAR) (RESTORE) Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) (REVIVAL) Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL) (ROC-ALPS) Resuscitation Outcomes Consortium (ROC) Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Ventricular Tachycardia (ALPS) (ROC-CCC) Resuscitation Outcomes Consortium (ROC) Trial Of Continuous Compressions Versus Standard CPR In Patients With Out-Of-Hospital Cardiac Arrest (CCC) (ROC-CPR) Resuscitation Outcomes Consortium (ROC) Controlled Study of the Clinical Effectiveness of Automated Real-Time Feedback on CPR Process Conducted at a Subset of ROC Sites (CPR) (ROC-Cardiac Epistry 1 and 2) Resuscitation Outcomes Consortium (ROC) Cardiac Epidemiologic Registry (Cardiac Epistry) Version 1 and 2 (ROC-Cardiac Epistry 3) Resuscitation Outcomes Consortium (ROC) Cardiac Epidemiologic Registry (Cardiac Epistry) Version 3 (ROC-HS/TBI) Resuscitation Outcomes Consortium (ROC) Hypertonic Saline Trial Shock Study (HS) and Traumatic Brain Injury Study (TBI) (ROC-PART) Resuscitation Outcomes Consortium (ROC) Pragmatic Trial of Airway Management in Out-of-Hospital Cardiac Arrest (PART) (ROC-PRIMED) Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve and Early Versus Delayed Analysis (PRIMED) (ROC-PROHS) Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation on Helicopter Study (PROHS) (ROC-PROPPR) Resuscitation Outcomes Consortium (ROC) Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) (ROC-Trauma Epistry) Resuscitation Outcomes Consortium (ROC) Trauma Epidemiologic Registry (Trauma Epistry) (ROMICAT-II) Rule Out Myocardial Ischemia/Infarction by Computer Assisted Tomography (ROMICAT-II) (ROSTERS) Randomized Order Safety Trial Evaluating Resident-physician Schedules Study (ROSTERS) (RTS) Raynaud's Treatment Study (RTS) (SCD-HeFT) Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) (SHEP) Systolic Hypertension in the Elderly Program (SHEP) (SHHS) Sleep Heart Health Study (SHHS) (SNAP) Study of Novel Approaches for Prevention (SNAP) (SOLVD) Studies of Left Ventricular Dysfunction (SOLVD) (SOYA) The Study of Soy Isoflavones in Asthma (SOYA) (SPIROMICS) Subpopulations and Intermediate Markers in COPD Study (SPIROMICS) (SPRINT) Systolic Blood Pressure Intervention Trial (SPRINT) (STAN) Study of Asthma and Nasal Steroids (STAN) (STICH) Surgical Treatment for Ischemic Heart Failure (STICH) (STOP II) Optimizing Primary Stroke Prevention in Children with Sickle Cell Anemia (STOP II) (TAAG) Trial of Activity for Adolescent Girls (TAAG) (TACT) Trial to Assess Chelation Therapy (TACT) (TCD) T-Cell Depletion in Unrelated Donor Marrow Transplantation (TCD) (THAPCA-IH) Therapeutic Hypothermia After Pediatric Cardiac Arrest (In-Hospital) (THAPCA-IH) (THAPCA-OH) Therapeutic Hypothermia After Pediatric Cardiac Arrest (Out of Hospital) (THAPCA-OH) (TIMI II) Thrombolysis in Myocardial Ischemia Trial II (TIMI II) (TIMI III) Thrombolysis in Myocardial Ischemia Trial III (TIMI III) (TMH CTN-RECESS) Transfusion Medicine and Hemostasis Clinical Trial Network (TMH CTN) - Red Cell Storage Duration Study (RECESS) (TMH CTN-RING) Transfusion Medicine and Hemostasis Clinical Trial Network (TMH CTN) - Resolving Infection in Neutropenia With Granulocytes (RING) (TOHP) Trials of Hypertension Prevention (TOHP) (TOLSURF) Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia: A Study in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide (TOLSURF) (TOPCAT) Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) (TRAP) Trial to Reduce Alloimmunization to Platelets (TRAP) (TSS) Transfusion Safety Study (TSS) (TTVS) Transfusion-Transmitted Viruses Study (TTVS) (VA2-TAH) VA Cooperative Study of the Efficacy of Hepatitis Immune Serum Globulin for the Prevention or Modification of Post-Transfusion Hepatitis (VA2-TAH) (VATS) Viral Activation Transfusion Study (VATS) (WAVE) Women's Angiographic Vitamin and Estrogen Trial (WAVE) (WHI-CTOS) Women's Health Initiative: Clinical Trial and Observational Study (WHI-CTOS) (WHI-LILAC) Women’s Health Initiative (WHI) - Life and Longevity After Cancer (LILAC) (WISE) Women's Ischemia Syndrome Evaluation (WISE) (WLM) Weight Loss Maintenance (WLM) (WNV) West Nile Virus Study (WNV) (WRAP-IPF) Weighing Risks and Benefits of Laparoscopic Anti-Reflux Surgery in Patients With Idiopathic Pulmonary Fibrosis (WRAP-IPF) (eMoms Roc) Electronically-Mediated Weight Interventions for Pregnant and Postpartum Women (e-Moms) of Rochester (Roc) (generic) Other (generic) (iCOMPARE) Individualized Comparative Effectiveness of Models Optimizing Patient Safety and Resident Education (iCOMPARE) (walk-PHaSST) Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy (walk-PHaSST)
Resources from multiple studies may be requested via one request form using the above drop down menu.
Describe this request, including a summary of the rationale, main hypothesis and proposed research aims *
A brief overview of your research needs.
Describe any additional requirements pertaining to the biospecimens themselves, such as anticoagulant used, additives, preservatives, etc.
Describe the characteristics of the subjects to be searched for available specimens. Criteria might include gender, age, disease status, genotype, etc. Be as specific as possible.
Requested study visit(s), if applicable
Only applicable for studies that have more than one specimen draw point. If any visit is acceptable, please indicate so. Refer to the "Available Biospecimens" tables on each study description page for more information regarding the available visits for each material type. If more than one visit is requested, please indicate if you can accept subjects that have specimens available from at least one, but not all of the requested visits.
Analyte(s) or parameter(s) to be tested *
Describe the assay(s) to be performed and include any test volume requirements.
Type of assay(s)/ platform(s) to be used *
Describe the assay kit(s)/platform(s) to be used, if applicable.
Rationale for number of biospecimens requested, including power calculations, and describe the use of covariates, if applicable *
Also describe your intended use of covariates from study datasets, if applicable.
Will the results be used for a commercial purpose?
Original Study Investigator? *
Were you an investigator with the original (parent) study(ies) referenced in this request?
Information Security: Please check the information security practices to be used
Provide the name of the cloud provider (e.g. Amazon Web Services, Microsoft Azure, Google Cloud Platform), and briefly indicate how the cloud computing service will be used to carry out the proposed project (e.g. what tools will be used and how these tools relate to the project).